WELLS FARGO & COMPANY/MN - F-STAR THERAPEUTICS INC ownership

F-STAR THERAPEUTICS INC's ticker is FSTX and the CUSIP is 30315R107. A total of 27 filers reported holding F-STAR THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of F-STAR THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$1,706
+70.6%
270
+104.5%
0.00%
Q3 2022$1,000
-99.9%
132
-99.9%
0.00%
Q2 2022$1,344,000214,719
+183420.5%
0.00%
Q1 2022$0
-100.0%
117
+0.9%
0.00%
Q4 2021$1,0000.0%116
+6.4%
0.00%
Q3 2021$1,0000.0%109
-5.2%
0.00%
Q2 2021$1,0000.0%115
+113.0%
0.00%
Q1 2021$1,00054
+125.0%
0.00%
Q4 2020$0240.00%
Other shareholders
F-STAR THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
DAFNA Capital Management LLC 714,285$6,136,0001.28%
Boxer Capital, LLC 1,751,428$15,045,0000.53%
Atlas Venture Advisors, Inc. 574,996$4,939,0000.51%
Monashee Investment Management LLC 400,000$3,436,0000.41%
Connolly Sarah T. 53,001$455,0000.37%
Rock Springs Capital Management LP 1,054,232$9,056,0000.18%
Eversept Partners, LP 100,000$859,0000.06%
Maven Securities LTD 144,932$1,257,0000.05%
Point72 Asset Management, L.P. 1,075,000$9,234,0000.04%
Private Capital Advisors, Inc. 13,083$112,0000.02%
View complete list of F-STAR THERAPEUTICS INC shareholders